CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

British biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

New Delhi: The lateral flow tests, which includes rapid-antigen and home-antigen tests, can detect COVID from the third day after exposure to the virus to day eight while the RT-PCR test can diagnose ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

The UK government recently asked all secondary schools to provide on-site COVID-19 testing for pupils, and advised secondary, college and university students to continue twice weekly testing, in an ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

Polymerase chain reaction (PCR) and rapid (antigen) tests for COVID-19 both involve taking a swab. Results for a PCR test take longer, as it needs to go to a laboratory. It is more costly but tends to ...

Avacta to replace antibodies in AffiDX test Finds test is less sensitive to Omicron at lower viral loads No timeline for sales resumption, shares plunge 26.5% Jan 10 (Reuters) - Britain's Avacta Group ...